Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature

NCT06683534 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT06683534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
December 31, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular diseases (cvd), microvascular dysfunction, microvascular health, microvasculature, obesity and overweight